Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Pharmacotherapy of late-life generalized anxiety disorder.

Trial Profile

Pharmacotherapy of late-life generalized anxiety disorder.

Phase of Trial: Phase IV

Latest Information Update: 10 May 2017

At a glance

  • Drugs Escitalopram (Primary)
  • Indications Generalised anxiety disorder
  • Focus Pharmacogenomic; Therapeutic Use
  • Most Recent Events

    • 21 Jan 2009 Results reported in JAMA: the Journal of the American Medical Association
    • 08 Sep 2008 Primary outcome updated as reported by ClinicalTrials.gov.
    • 08 Sep 2008 Actual end date (Apr 2008) added as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top